BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17656488)

  • 1. Low and nontoxic inorganic mercury burdens attenuate BCR-mediated signal transduction.
    McCabe MJ; Laiosa MD; Li L; Menard SL; Mattingly RR; Rosenspire AJ
    Toxicol Sci; 2007 Oct; 99(2):512-21. PubMed ID: 17656488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mercury alters endogenous phosphorylation profiles of SYK in murine B cells.
    Caruso JA; Carruthers N; Shin N; Gill R; Stemmer PM; Rosenspire A
    BMC Immunol; 2017 Jul; 18(1):37. PubMed ID: 28716125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syk mediates BCR- and CD40-signaling integration during B cell activation.
    Ying H; Li Z; Yang L; Zhang J
    Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
    Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
    Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
    Purkerson JM; Parker DC
    J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low and nontoxic levels of ionic mercury interfere with the regulation of cell growth in the WEHI-231 B-cell lymphoma.
    McCabe MJ; Santini RP; Rosenspire AJ
    Scand J Immunol; 1999 Sep; 50(3):233-41. PubMed ID: 10447931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
    Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
    Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation.
    Chen L; Juszczynski P; Takeyama K; Aguiar RC; Shipp MA
    Blood; 2006 Nov; 108(10):3428-33. PubMed ID: 16888096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
    J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab inhibits B-cell receptor signaling.
    Kheirallah S; Caron P; Gross E; Quillet-Mary A; Bertrand-Michel J; Fournié JJ; Laurent G; Bezombes C
    Blood; 2010 Feb; 115(5):985-94. PubMed ID: 19965664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells.
    Li YY; Baccam M; Waters SB; Pessin JE; Bishop GA; Koretzky GA
    J Immunol; 1996 Aug; 157(4):1440-7. PubMed ID: 8759724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems toxicology approach identifies Lyn as a key signaling phosphoprotein modulated by mercury in a B lymphocyte cell model.
    Caruso JA; Stemmer PM; Dombkowski A; Caruthers NJ; Gill R; Rosenspire AJ
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):47-54. PubMed ID: 24440445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
    Maeda A; Scharenberg AM; Tsukada S; Bolen JB; Kinet JP; Kurosaki T
    Oncogene; 1999 Apr; 18(14):2291-7. PubMed ID: 10327049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The B cell receptor promotes B cell activation and proliferation through a non-ITAM tyrosine in the Igalpha cytoplasmic domain.
    Patterson HC; Kraus M; Kim YM; Ploegh H; Rajewsky K
    Immunity; 2006 Jul; 25(1):55-65. PubMed ID: 16860757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk.
    Zhang Y; Wienands J; Zürn C; Reth M
    EMBO J; 1998 Dec; 17(24):7304-10. PubMed ID: 9857187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells.
    Gill R; McCabe MJ; Rosenspire AJ
    Toxicol Appl Pharmacol; 2017 Sep; 330():22-29. PubMed ID: 28668464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
    Pao LI; Cambier JC
    J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.